Fed. Circ. Weighs Scientists' Ties To Cancer Patents
A Federal Circuit panel grappled Friday with where to draw the line between collaboration and significant contributions in determining whether a district court wrongly ordered two scientists to be named as...To view the full article, register now.
Already a subscriber? Click here to view full article